AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2017
Jan 25, 2017
34129_dirs_2017-01-25_c167f45b-342c-4b19-958e-583cae777b23.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2017-01-24
Reporting Person: Ferrante Karen Jean (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-01-24 | Stock Option (right to buy) | $18.52 | A | 20000 | Acquired | 2027-01-24 | Common Stock (20000.0) | Direct |
Footnotes
F1: The option will vest 1/12th of the shares monthly, beginning on the first monthly anniversary of the grant date and will become fully exercisable 1 year from the date of grant (1/24/18).
More from MACROGENICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 13
Merger & Acquisition
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18